ASTS
AST SpaceMobile, Inc.
ASTS has a slight edge over NYAX overall, supported by stronger modeled upside and stronger valuation.
NYAX
Nayax Ltd.
NYAX's outlook is improving, though it still trails on the overall score.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
NYAX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Healthy | |
| Healthy |
NYAX's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
NYAX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 48x | $52.18 | — |
| Cheap | 66x | $13.83 | -73% |
| Fair | 82x | $17.22 | -67% |
| Expensive | 228x | $47.78 | -8.4% |
| Current | 246x | $52.18 | — |
Historical ranges are pointers, not guarantees.
NYAX's PE is in its expensive range at 246x. If earnings grow as analysts expect, today's price would be 48x next year's earnings, in its cheap range.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
NYAX Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for NYAX, with profitability improving.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
NYAX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.08 | +414% |
| Q2 2026 | $0.21 | -63% |
| Q1 2026 | $0.79 | +339% |
| Q4 2025 | $0.96 | +$1.13 |
| Q3 2025 | $0.65 | +$0.96 |
| Q2 2025 | $0.57 | +$1.00 |
| Q1 2025 | $0.18 | +$0.64 |
| Q4 2024 | -$0.17 | +$0.31 |
| Q3 2024 | -$0.31 | +$0.30 |
NYAX has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS's revenue has grown year over year for 11 quarters in a row: $42M last quarter, up 187% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
NYAX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $122.6M | +28% |
| Q1 2026 | $105.9M | +31% |
| Q4 2025 | $121.9M | +37% |
| Q3 2025 | $105.8M | +27% |
| Q2 2025 | $95.6M | +22% |
| Q1 2025 | $81.1M | +27% |
| Q4 2024 | $89M | +27% |
| Q3 2024 | $83M | +38% |
NYAX's revenue has grown year over year every quarter since early 2021: $123M last quarter, up 28% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -5.4% | -15 points |
| Q1 2026 | 3.9% | -5.9 points |
| Q4 2025 | 11% | +6.9 points |
| Q3 2025 | 8.3% | +6.5 points |
| Q2 2025 | 10% | +8.8 points |
| Q1 2025 | 9.7% | +14 points |
| Q4 2024 | 4% | +5.9 points |
| Q3 2024 | 1.8% | +4.2 points |
NYAX has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
NYAX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$3.7M | -167% |
| Q1 2026 | $977.3K | +$6.7M |
| Q4 2025 | $16.3M | +76% |
| Q3 2025 | $15.5M | +53% |
| Q2 2025 | $5.6M | +91% |
| Q1 2025 | -$5.7M | -$1.3M |
| Q4 2024 | $9.3M | +$10.8M |
| Q3 2024 | $10.1M | +1431% |
NYAX has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
NYAX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -9.6% | -4M shares |
| 1 year | -0.6% | -211K shares |
| 3 years | +14% | +4.6M shares |
| 5 years | +23% | +7.1M shares |
| Available history | +51% | +12.7M shares |
NYAX has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
NYAX hasn't bought back shares in the past year.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NYAX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 1.0x | Healthy |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -1.5x | Net Cash |
| Q2 2025 | -0.2x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -1.1x | Net Cash |
| Q3 2024 | -0.5x | Net Cash |
NYAX's net debt is about a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
NYAX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.5 | Neutral |
| Stochastic | 28.3 | Neutral |
NYAX's weekly RSI is 48 (neutral) and its Stochastic is 28 (neutral).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
NYAX PE vs Technology Sector
| Metric | NYAX | Sector median | Relative |
|---|---|---|---|
| PE | 246x | 28x | 781% above |
| PE % | 91 | 40 | 51 pts above |
NYAX is trading at 246x earnings, a 781% premium to the Technology sector's median of 28x.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
NYAX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $47.7 | 9.3% above |
| 20 week MA | $54.0 | 3.4% below |
| 50 week MA | $57.2 | 8.8% below |
| 100 week MA | $49.3 | 5.8% above |
| 200 week MA | $36.0 | 45% above |
NYAX has the edge over ASTS on trend strength, trading above more of its moving averages.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
NYAX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $26.5 | $19.7 | -26% |
| 2023 | $19.7 | $19.1 | -3.3% |
| 2024 | $19.1 | $27.8 | +46% |
| 2025 | $27.8 | $48.3 | +74% |
| 2026 YTD | $48.3 | $52.2 | +8% |
NYAX has the edge over ASTS on returns for 2026, with the stronger performance.